Oncology
Radiopharmaceutical development is accelerating. Preclinical...
Radiopharmaceuticals are rapidly becoming one of the most dynamic areas of oncology drug development.
News
Gilead strikes again, penning $5bn deal to buy Tubulis
Gilead has signed its third acquisition deal since the start of the year, agreeing to buy ADC specialist Tubulis for $3.15bn upfront.
News
AZ claims another win for Imfinzi in frontline liver cancer
AstraZeneca has built the case for Imfinzi in earlier-stage liver cancer with a second phase 3 trial readout in its EMERALD programme.
News
DNA testing can help right racial imbalance in breast cancer
Study suggests routine genomic testing could correct well-established disparities in breast cancer survival rates between white and Black women.
News
Blackstone closes record $6.3bn life sciences fund
Blackstone has closed its latest fund – the $6.3bn BXLS VI – saying it is the largest ever private fund for the life sciences sector.
News
Views & Analysis
Deep Dive
Editor's Picks
Editor's Picks
